Ouimette Mike

General Counsel & Corp. Sec'yPLIANT THERAPEUTICS, INC. (PLRX) · full profile →Form 4 · filed Jan 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$261K
Net Open-Market Flow
-$261K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2025Sell(S)10K$10.99$112K71K
Jan 17, 2025Sell(S)13K$11.20$149K81K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746473-25-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly: